Skip to main content
NewslettersWatchlist

Ligand Pharm(LGND-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time

Ligand Pharm

555 HERITAGE DRIVE SUITE 200
JUPITER FL 33458 USA
P: 858-550-7500
http://www.ligand.com

Profile

Ligand, being a biotechnology company, focuses on developing/acquiring royalty revenue generating assets and coupling them with a lean corporate cost structure. Ligand's Captisol formulation technology has allowed it to enter into several licensing deals and generate royalties. Captisol is a well validated chemically modified cyclodextrin that is designed to improve safety and solubility, stability, and bioavailability or lessen the volatility, irritation, smell or taste of drugs. Ligand has merged with CyDex. By this, it added an antibody-generating platform, OmniAb, to the company's portfolio. Its other technology platforms include antigen discovery platform & protein expression platform. All these technologies have created a strong platform for Ligand to seek new licenses and partnerships. Ligand has partnership agreements with leading healthcare companies like Novartis, Amgen, Merck, Pfizer, Celgene, Gilead & Lilly, etc. The company continues to buy smaller companies to increase its technology platforms.

Key Executives

NameTitle
Todd C. DavisCEO/Director
Matthew KorenbergCOO/President
Octavio EspinozaCFO/Chief Accounting Officer
Andrew ReardonChief Legal Officer/Secretary

More from The Globe

Nvidia sparks chatter over possible Dow inclusion after stock split
A person walks pass a Nvidia logo at Computex in Taipei, Taiwan June 5, 2024.
The close: TSX gets a bump after oil prices reach one-week high
Traders work on the floor of the New York Stock Exchange during afternoon trading on June 3.
What every Canadian investor needs to know today
An overview shows traders work in front of a chart of Germany's share index DAX that is diplayed (in background) at the stock exchange in Frankfurt am Main, western Germany, on June 5, 2024. (Photo by Daniel ROLAND / AFP) (Photo by DANIEL ROLAND/AFP via Getty Images)
Berkshire buys additional 2.57 million shares in Occidental Petroleum, filing shows
FILE PHOTO: The logo for Occidental Petroleum is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 30, 2019. REUTERS/Brendan McDermid/File Photo
The close: TSX falls as bond yields climb after strong U.S. jobs report
Traders work on the floor of the New York Stock Exchange during afternoon trading on June 3.
What every Canadian investor needs to know today
NEW YORK, NEW YORK - JUNE 03: Traders work on the floor of the New York Stock Exchange during afternoon trading on June 03, 2024 in New York City. Stocks closed mixed on the first day of trading in June a day that started with a technical issue that was resolved that brought trading to a stop for some of the major stocks and caused Berkshire Hathaway to be down 99.97%. (Photo by Michael M. Santiago/Getty Images)
The close: Resource shares lift TSX ahead of jobs reports
A specialist trader works at his post on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., June 3.
What every Canadian investor needs to know today
Traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., June 3, 2024. REUTERS/Brendan McDermid

All market data (will open in new tab) is provided by Barchart Solutions. Copyright ยฉ 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.